Abdul Mannan: Two Battles, One Patient – Why Women on Anticoagulants Need Better Coordinated Care
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Too many young females on anticoagulants are fighting two battles at once:
the clot… and their periods.
Our new BloodDoctor infographic highlights a problem that still flies under the radar:
Up to 60% of patients on blood thinners experience gynaecologic bleeding.
For many, it’s not just inconvenient — it leads to iron deficiency, anaemia, and in some cases, life-threatening haemorrhagic ovarian cysts.
What struck me most while creating this resource is how often these patients end up navigating it alone, without joined-up support between haematology and gynaecology.
The evidence is clear:
1. Bleeding risk varies by drug type.
Vitamin K antagonists: 22–71%
Rivaroxaban: up to 43%
2. Multidisciplinary care changes outcomes.
The safest and most effective approach brings together:
• Haematology
• Gynaecology / Adolescent Medicine
• Primary Care
• A coordinated clinic model where decisions are shared rater than made in isolation.
When these teams work together, patients avoid the unnecessary suffering created by abrupt contraceptive changes, untreated heavy bleeding, and delayed referrals.
This is a call for better collaboration, not more complexity.
- How are your teams managing gynaecologic bleeding in patients on anticoagulants?
- What has helped improve outcomes in your service?
Let’s move the conversation forward — patients deserve nothing less.”

Find more posts featuring Abdul Mannan on Hemostasis Today.
-
Dec 11, 2025, 12:27Roula Farah: Discussing Rare Bleeding Disorders in Abu Dhabi
-
Dec 11, 2025, 12:21Amirali Ebrahimpour: Escherichia coli–Related DIC Case Report
-
Dec 11, 2025, 12:08Laura Girardi Compares US, CT and MRI in Portal Vein Thrombosis
-
Dec 11, 2025, 11:55Dino Mehic on BDUC: What Do We Know?
-
Dec 11, 2025, 11:39Post‑ASH25 Reflection from Hollie Knight: The Magic Isn’t Just in the Data, It’s in How We Move It
-
Dec 11, 2025, 06:23Robert Negrin is the President of ASH for 2026
-
Dec 10, 2025, 22:36Susan Galbraith on AstraZeneca’s Grand Presence at ASH25
-
Dec 10, 2025, 22:0212 Posts Not to Miss From the ASH 2025 – Wolfgang Miesbach
-
Dec 10, 2025, 17:22In the Fight for Hematology: Adetokunbo O’s Reflections from ASH25
